Triplet Therapeutics
A therapeutics company developing siRNA and ASO therapeutics that target repeat expansion disorders such as Huntington’s disease, myotonic dystrophy and spinocerebellar ataxias
1
Funding Rounds
$59.0m
Money raised
Overview
A therapeutics company developing siRNA and ASO therapeutics that target repeat expansion disorders such as Huntington’s disease, myotonic dystrophy and spinocerebellar ataxias
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ne**** Be******** | - | - |
Funding series
Funding Series Analysis
The company Triplet Therapeutics has raised a total of $59m in funding over 1 rounds.
Key Insights:
- Tripley Therapeutics Series A round, December 2019: $59m
Tripley Therapeutics Series A round, December 2019
$59m
Industries
Triplet Therapeutics is active in the following industries:
- RNA-based and RNA-targeted therapeutics
- Therapeutics
- Technology
- Biology
- Biotechnology